Copyright
©The Author(s) 2020.
World J Stem Cells. Jun 26, 2020; 12(6): 514-526
Published online Jun 26, 2020. doi: 10.4252/wjsc.v12.i6.514
Published online Jun 26, 2020. doi: 10.4252/wjsc.v12.i6.514
Table 2 Clinical outcomes according to the International Cartilage Repair Society grading system
ICRS grade I (n = 73) | ICRS grade II (n = 37) | ICRS grade III (n = 15) | P value1 | Post hoc5 | |
IKDC | |||||
Preoperative | 28.4 ± 7.4 | 30.1 ± 7.2 | 29.2 ± 8.1 | 0.610 | |
1 yr | 59.3 ± 8.7 | 52.4 ± 10.7 | 54.8 ± 7.1 | 0.005 | I > II = III,I = III |
2 yr | 64.3 ± 9.2 | 58.6 ± 11.1 | 55.0 ± 8.0 | < 0.001 | I > II = III |
3 yr | 68.1 ± 10.8 | 61.0 ± 11.3 | 59.3 ± 5.8 | < 0.001 | I > II = III |
P value2 | < 0.001 | < 0.001 | 0.001 | ||
P value3 | < 0.001 | < 0.001 | 0.842 | ||
P value4 | 0.001 | 0.063 | 0.047 | ||
WOMAC | |||||
Preoperative | 45.1 ± 11 | 41.9 ± 9.2 | 44.3 ± 12.2 | 0.275 | |
1 yr | 11.0 ± 6.9 | 16.8 ± 8.5 | 17.6 ± 5.1 | < 0.001 | I > II = III |
2 yr | 8.4 ± 6.0 | 13.4 ± 8.2 | 17.3 ± 7.4 | < 0.001 | I > II = III |
3 yr | 6.5 ± 6.0 | 10.5 ± 5.6 | 12.6 ± 8.3 | < 0.001 | I > II = III |
P value2 | < 0.001 | < 0.001 | 0.001 | ||
P value3 | < 0.001 | 0.001 | 0.607 | ||
P value4 | 0.003 | 0.002 | 0.018 | ||
VAS | |||||
Preoperative | 7.6 ± 1.4 | 7.5 ± 1.1 | 7.7 ± 0.8 | 0.817 | |
1 yr | 2.1 ± 1.7 | 3.0 ± 1.6 | 3.3 ± 1.2 | 0.002 | I > II = III |
2 yr | 1.5 ± 1.4 | 2.7 ± 1.8 | 3.1 ± 1.2 | < 0.001 | I > II = III |
3 yr | 1.1 ± 1.5 | 2.0 ± 1.4 | 2.6 ± 0.9 | < 0.001 | I > II = III |
P value2 | < 0.001 | < 0.001 | 0.001 | ||
P value3 | < 0.001 | 0.229 | 0.658 | ||
P value4 | 0.004 | 0.019 | 0.103 |
- Citation: Song JS, Hong KT, Kong CG, Kim NM, Jung JY, Park HS, Kim YJ, Chang KB, Kim SJ. High tibial osteotomy with human umbilical cord blood-derived mesenchymal stem cells implantation for knee cartilage regeneration. World J Stem Cells 2020; 12(6): 514-526
- URL: https://www.wjgnet.com/1948-0210/full/v12/i6/514.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i6.514